Healthcare Bearish Stocks: Illumina (NASDAQ:ILMN), The Clorox Co (NYSE:CLX), Dyax Corp. (NASDAQ:DYAX), Alexion Pharmaceuticals (NASDAQ:ALXN)

Illumina (NASDAQ:ILMN) SVP Nicholas Naclerio unloaded 2,000 shares of Illumina stock in a transaction that occurred on Monday, March 17th. Illumina, Inc. (NASDAQ:ILMN) stock performance was -5.42% in last session and finished the day at $152.60. Traded volume was 4,483,791 million shares in the last session and the average volume of the stock remained 1.99 million shares. The beta of the stock remained 0.44. Illumina, … Continue reading Healthcare Bearish Stocks: Illumina (NASDAQ:ILMN), The Clorox Co (NYSE:CLX), Dyax Corp. (NASDAQ:DYAX), Alexion Pharmaceuticals (NASDAQ:ALXN)

NASDAQ Gainers: NewLink Genetics Corporation (NASDAQ:NLNK), ChinaNet Online Holdings, Inc. (NASDAQ:CNET), Canadian Solar Inc. (NASDAQ:CSIQ), On Track Innovations (NASDAQ:OTIV), Illumina Inc. (NASDAQ:ILMN)

NewLink Genetics Corporation (NASDAQ:NLNK) said it entered into an agreement with Roche Holding AG to develop NewLink’s cancer immunotherapy, making the Ebola vaccine developer eligible to receive over $1 billion in milestone payments. NewLink Genetics Corporation (NASDAQ:NLNK) belongs to Healthcare sector. Its weekly performance is 58.04%. On last trading day company shares ended up $34.50. NewLink Genetics Corporation (NASDAQ:NLNK) distance from 50-day simple moving average … Continue reading NASDAQ Gainers: NewLink Genetics Corporation (NASDAQ:NLNK), ChinaNet Online Holdings, Inc. (NASDAQ:CNET), Canadian Solar Inc. (NASDAQ:CSIQ), On Track Innovations (NASDAQ:OTIV), Illumina Inc. (NASDAQ:ILMN)

Healthcare Insider Selling: Illumina (NASDAQ:ILMN), Raptor Pharmaceutical (NASDAQ:RPTP), Stryker Corporation (NYSE:SYK), United Therapeutics Corporation (NASDAQ:UTHR), CareFusion Corporation (NYSE:CFN)

Illumina (NASDAQ:ILMN) Director Daniel Bradbury sold 2,100 shares of the stock on the open market in a transaction dated Tuesday, July 8th. The shares were sold at an average price of $172.89, for a total value of $363,069.00. Following the sale, the director now directly owns 12,466 shares in the company, valued at approximately $2,155,247. Illumina, Inc. (NASDAQ:ILMN) stock performance was 2.51% in last session … Continue reading Healthcare Insider Selling: Illumina (NASDAQ:ILMN), Raptor Pharmaceutical (NASDAQ:RPTP), Stryker Corporation (NYSE:SYK), United Therapeutics Corporation (NASDAQ:UTHR), CareFusion Corporation (NYSE:CFN)

Biotech Insider Selling: Achillion Pharmaceuticals (NASDAQ:ACHN), MannKind Corporation (NASDAQ:MNKD), Questcor Pharmaceuticals Inc (NASDAQ:QCOR), Dyax Corp. (NASDAQ:DYAX), Illumina (NASDAQ:ILMN)

Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) Director Gary E. Frashier unloaded 55,000 shares of the stock on the open market in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $8.00, for a total transaction of $440,000.00. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock performance was -3.07% in last session and finished the day at $7.58. Traded volume was 13.15million shares … Continue reading Biotech Insider Selling: Achillion Pharmaceuticals (NASDAQ:ACHN), MannKind Corporation (NASDAQ:MNKD), Questcor Pharmaceuticals Inc (NASDAQ:QCOR), Dyax Corp. (NASDAQ:DYAX), Illumina (NASDAQ:ILMN)